Canary Capital has taken a pioneering step by filing for the first-ever staked Injective ETF with the U.S. Securities and Exchange Commission, sparking a nearly 5% surge in INJ’s price in the past 24 hours.
The ETF, called the Canary Staked INJ ETF, aims to give investors direct, regulated access to Injective’s staking ecosystem. Instead of passively holding tokens, the fund will actively stake INJ on the proof-of-stake Injective network, allowing investors to tap into DeFi-native yield through a traditional investment vehicle.
The filing reflects growing institutional interest in Injective, which has attracted support from players like Google Cloud and T-Mobile, and follows Injective Labs’ engagement with the SEC on DeFi regulation policy.
Canary Capital had previously submitted ETF applications for XRP and Solana, and recently established a Delaware trust for the staked INJ fund to support regulatory approval efforts.
The proposal lands during a crucial moment in U.S. crypto policy, as Congress debates multiple bills under the banner of Crypto Week 2025—decisions that could directly shape the future of this ETF and others like it.
Alexander Stefanov
Reporter at Coindoo
Alex is an experienced financial journalist and cryptocurrency enthusiast. With over 8 years of experience covering the crypto, blockchain, and fintech industries, he is well-versed in the complex and ever-evolving world of digital assets. His insightful and thought-provoking articles provide readers with a clear picture of the latest developments and trends in the market. His approach allows him to break down complex ideas into accessible and in-depth content. Follow his publications to stay up to date with the most important trends and topics.
Source: https://coindoo.com/canary-capital-moves-to-bring-staked-inj-to-wall-street-with-a-new-etf/